European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for appendiceal neuroendocrine tumours (aNET)

Gregory Kaltsas1, Thomas Walter2, Ulrich Knigge3

  • 11st Propaedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.

PubMed

Insights

This guidance paper updates expert recommendations for diagnosing and managing well-differentiated appendiceal neuroendocrine tumors (aNET). It addresses uncertainties and controversial issues using the best available evidence and expert experience.

Area of Science:

  • Gastroenterology
  • Oncology
  • Endocrinology

Background:

  • Appendiceal neuroendocrine tumors (aNET) require updated diagnostic and management guidelines.
  • Previous European Neuroendocrine Tumor Society (ENETS) guidelines need revision.
  • Poorly differentiated neoplasms are addressed separately.

Purpose of the Study:

  • To provide practical guidance for the diagnosis and management of well-differentiated appendiceal NET (aNET).
  • To address controversial issues and areas of uncertainty in aNET management and follow-up.
  • To update existing ENETS guidelines on aNET.

Main Methods:

  • Guidance paper structured in a question-answer format.
  • Recommendations based on the best available evidence.
  • Inclusion of authors' clinical experience in managing aNET.
  • Utilizing the GRADE system (adapted) for evidence and recommendation grading.

Main Results:

  • Provides updated, practical guidance for aNET diagnosis and management.
  • Clarifies recommendations for controversial and uncertain aspects of aNET care.
  • Offers evidence-based and expert-opinion-driven recommendations.

Conclusions:

  • The updated guidance offers a comprehensive resource for clinicians managing aNET.
  • Addresses critical knowledge gaps and provides clear recommendations.
  • Aims to improve patient outcomes through standardized, evidence-based care.